• Borrego B, Carra E, Garcia-Ranea J A. Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus[J]. J Gen Virol, 2002, 83(): 35-44. doi: 10.1099/0022-1317-83-1-35

  • Brocchi E, Zhang G, Knowles N J. Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987-1994[J]. Epidemiol Infect, 1997, 118(): 51-61. doi: 10.1017/S0950268896007170

  • Dekker A. Herd sensitivity in relation to test sensitivity in swine vesicular disease serological tests[J]. Rev sci tech Off int Epiz, 2005, 24(3): 1077-1083.

  • Graves J H. 1986. Swine vesicular disease. In: Diseases of Swine (Leman A D, Straw B, Glock R D, et al Eds.), 6th ed., Ames:Iowa State University Press, p384-352.

  • Hu W S, Pathak V K. Design of retroviral vector and helper cells for gene therapy[J]. Pharmacol Rev, 2000, 52(): 493-511.

  • Inoue T, Suzuli T, Sekiguchi K. The complete nucleotide sequence of swine vesicular disease virus[J]. J Gen Virol, 1989, 70(): 919-934. doi: 10.1099/0022-1317-70-4-919

  • Jimenez-Clavero M A, Douglas A, Lavery T. Immune recognition of swine vesicular disease virus structural proteins: novel antigenic regions that are not exposed in the capsid[J]. Virol, 2000, 270(): 76-83. doi: 10.1006/viro.2000.0256

  • Kanno T, Inoue T, Wang Y. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants[J]. J Gen Virol, 1995, 76(): 3099-3106. doi: 10.1099/0022-1317-76-12-3099

  • Kanno T, Mackay D, Inoue T. Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus[J]. J Virol, 1999, 73(): 2710-2716.

  • Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes[J]. Cell, 1986, 44(): 283-292. doi: 10.1016/0092-8674(86)90762-2

  • Kwon Y J, Hung G, Anderson W F. Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis[J]. J Virol, 2003, 77(): 5712-5720. doi: 10.1128/JVI.77.10.5712-5720.2003

  • Nardelli L, Lodetti E, Gualandi G L. A foot and mouth disease syndrome in pigs caused by an enterovirus[J]. Nature, 1968, 219(): 1275-1276. doi: 10.1038/2191275a0

  • Nijhar S K, Mackay D K., Brocchi E. Identification of neutralizing epitopes on a European strain of swine vesicular disease virus[J]. J Gen Virol, 1999, 80(): 277-282. doi: 10.1099/0022-1317-80-2-277

  • Rebel J M, Leendertse C H, Dekker A. Construction of a full-length infectious cDNA clone of swine vesicular disease virus strain NET/1/92 and analysis of new antigenic variants derived from it[J]. J Gen Virol, 2000, 81(): 2763-2769. doi: 10.1099/0022-1317-81-11-2763

  • Tsuda T, Tokui T, Onodera T. Induction of neutralizing antibodies by structural proteins VP1 and VP2 of swine vesicular disease virus[J]. Jap J Vet Sci, 1987, 49(): 129-132. doi: 10.1292/jvms1939.49.129

  • Sun S Q, Liu X T, Guo H C. Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus[J]. J Gen Virol, 2007, 88(Pt 3): 842-848.

  • Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy[J]. J Gen Med, 2000, 2(): 308-316. doi: 10.1002/(ISSN)1521-2254

  • Zheng H X, Liu X T, Shang Y J. Infective viruses produced from full-length complemen-tary DNA of swine vesicular disease viruses HK/70 strain[J]. Chin Sci Bull, 2006, 51(): 2072-2078. doi: 10.1007/s11434-006-2095-z

  • Ye G S, Liu X T, Zhang Y M. Determination and Analysis of Complete Nucleotide Sequence of Swine Vesicular Disease Virus[J]. Chin J Virol, 2005, 21(1): 69-71.